(VIANEWS) – The NASDAQ ended the session with Catalyst Pharmaceuticals (CPRX) rising 5.61% to $8.29 on Tuesday while NASDAQ jumped 1.95% to $14,108.82.

Volume

Today’s last reported volume for Catalyst Pharmaceuticals is 1486480, 33.97% above its average volume of 1109540.

Catalyst Pharmaceuticals’s last close was $7.85, 3.56% higher than its 52-week high of $7.58.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 18% for the ongoing quarter and 15.6% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 126.9M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Catalyst Pharmaceuticals’s stock is considered to be oversold (<=20).

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $8.29 at 17:25 EST, higher than its 52-week high of $7.58.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s value is way above its 50-day moving average of $6.53 and way above its 200-day moving average of $5.51.

More news about Catalyst Pharmaceuticals (CPRX).

LEAVE A REPLY

Please enter your comment!
Please enter your name here